Brijesh Rathi

InstitutionUniversity of Delhi
AddressDelhi
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 1 publications in January 2020 and June 2020 and August 2020 and November 2020 and January 2021 and February 2021 and April 2021 and May 2021 and June 2021 and July 2021
    All Publications
    Bar chart showing 27 publications over 9 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rolta R, Salaria D, Sharma P, Sharma B, Kumar V, Rathi B, Verma M, Sourirajan A, Baumler DJ, Dev K. Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach. Curr Pharmacol Rep. 2021; 7(4):135-149. PMID: 34306988.
      Citations: 3     
    2. Sharma PP, Kumar S, Srivastava S, Srivastava M, Jee B, Gorobets NY, Kumar D, Kumar M, Asthana S, Zhang P, Zoltner M, Rathi B. Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus. J Biomol Struct Dyn. 2021 Jun 21; 1-19. PMID: 34151735.
      Citations:    Fields:    
    3. Chandel V, Tripathi G, Nayar SA, Rathi B, Kumar A, Kumar D. In silico identification and validation of triarylchromones as potential inhibitor against main protease of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn. 2021 May 03; 1-16. PMID: 33939590.
      Citations:    Fields:    
    4. Mathur A, Raj S, Jha NK, Jha SK, Rathi B, Kumar D. Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2. 3 Biotech. 2021 May; 11(5):236. PMID: 33936927.
      Citations:    
    5. Kumar S, Sharma PP, Upadhyay C, Kempaiah P, Rathi B. Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies. Methods. 2021 11; 195:44-56. PMID: 33639316.
      Citations: 1     Fields:    Translation:HumansCells
    6. Gupta Y, Maciorowski D, Zak SE, Jones KA, Kathayat RS, Azizi SA, Mathur R, Pearce CM, Ilc DJ, Husein H, Herbert AS, Bharti A, Rathi B, Durvasula R, Becker DP, Dickinson BC, Dye JM, Kempaiah P. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021 11; 195:57-71. PMID: 33453392.
      Citations: 5     Fields:    Translation:HumansCells
    7. Srivastava S, Verma S, Kamthania M, Agarwal D, Saxena AK, Kolbe M, Singh S, Kotnis A, Rathi B, Nayar SA, Shin HJ, Vashisht K, Pandey KC. Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide. J Biomol Struct Dyn. 2022 Mar; 40(5):2369-2388. PMID: 33155524.
      Citations: 5     Fields:    
    8. Chandel V, Sharma PP, Raj S, Choudhari R, Rathi B, Kumar D. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. J Biomol Struct Dyn. 2022 01; 40(1):249-262. PMID: 32838660.
      Citations: 12     Fields:    Translation:HumansCells
    9. Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P, Rathi B. Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies. J Chem Inf Model. 2020 12 28; 60(12):5754-5770. PMID: 32551639.
      Citations: 21     Fields:    Translation:HumansCells
    10. Kumar S, Rathi B. Coronavirus Disease COVID-19: A New Threat to Public Health. Curr Top Med Chem. 2020; 20(8):599-600. PMID: 32133964.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health